Pathology internationalHumansNeoplasmsCD163 AntigenAntigensCD
Therapeutic Strategies Targeting CD163 and CD169 in Macrophages for Cancer.
Yukio Fujiwara, Yoshihiro Komohara
Published: 202510.1111/pin.70062
Abstract
Macrophage activation markers, specifically CD163 and CD169, play pivotal roles in the modulation of immune responses within the tumor microenvironment (TME), influencing the outcome of various cancers. These markers delineate the activation states o…
Preview only. Read the full abstract at the source